PROCÉDÉ DE MÉTATHÈSE COMPRENANT L'EXTRACTION DE L'ÉTHYLÈNE FORME AU MOYEN D'UNE MEMBRANE
    71.
    发明公开
    PROCÉDÉ DE MÉTATHÈSE COMPRENANT L'EXTRACTION DE L'ÉTHYLÈNE FORME AU MOYEN D'UNE MEMBRANE 审中-公开
    与乙烯提取易位由膜的方式

    公开(公告)号:EP2976314A1

    公开(公告)日:2016-01-27

    申请号:EP14716886.8

    申请日:2014-03-18

    申请人: Arkema France

    摘要: The invention relates to a process for the metathesis of two α‑olefin compounds, characterized in that it comprises the use of at least one membrane for extracting ethylene from the reaction medium, said membrane being permeable to gases and impermeable to liquids. The invention relates more particularly to a process for the metathesis of two α‑olefin compounds, carried out in a reaction device comprising two zones separated by said at least one membrane: - a first zone, fed with reactants and catalyst, in which the liquid-phase metathesis reaction is initiated and the liquid reaction medium is circulated in contact with the wall constituted by the membrane, and - a second zone, fed with a gaseous stream that is inert with respect to the membrane and the constituents of the reaction medium of the first zone, optionally under a pressure slightly lower than that in the first zone or in the form of a purge by a gas flow at sufficient flow rate, so as to drive the migration, by diffusion, of the ethylene dissolved in the reaction medium from the first zone to the second zone.

    A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM
    75.
    发明授权
    A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM 有权
    用于生产外消旋西酞普兰,二醇和/或S-或R-西酞普兰-DIOLEN及其用途用于生产外消旋体西酞普兰,R-西酞普兰和/或S-西酞普兰

    公开(公告)号:EP1581483B1

    公开(公告)日:2012-06-06

    申请号:EP03767476.9

    申请日:2003-12-18

    申请人: H. Lundbeck A/S

    IPC分类号: C07C253/34 C07D307/87

    CPC分类号: C07D307/87 C07C253/34

    摘要: In the following, citalopram diol means 4-(4-(dimethylamino)-l­-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)-benzonitrile, as free base and/or acid addition salt. The invention relates to a process for the preparation of racemic citalopram diol and/or R- or S-citalopram diol, comprising the separation of a non-racemic mixture of R- and S-citalopram diol with more than 50% of one of the enantiomers into a fraction being enriched with S- or R-citalopram diol and a fraction comprising RS-citalopram diol wherein the ratio of R-citalopram diol:S-citalopram diol is equal to 1:1 or closer to 1:1 than in the initial mixture. The method is characterized in that (i) RS-citalopram diol is precipitated from a solution of the initial non-racemic mixture, or R- or S-citalopram diol is dissolved into a solvent from the initial non-racemic mixture, leaving a residue of RS-citalopram diol, and in that (ii) the residue/precipitate formed is separated from the final solution phase, followed by optional steps of repetition, recrystallisation, purification, isolation and conversion between free base and salts. The invention also relates to a process for the preparation of RS-citalopram, S-citalopram or R-citalopram (all as free base and/or acid addition salt) comprising the method described above followed by ring closure.

    Mixtures comprising 6-aminocapronitrile, tetrahydroazepine and hexamethylenediamin.
    76.
    发明公开
    Mixtures comprising 6-aminocapronitrile, tetrahydroazepine and hexamethylenediamin. 审中-公开
    Gemische enthaltend 6-Aminocapronitril,四氢吖庚因和六亚甲基二胺。

    公开(公告)号:EP2450345A1

    公开(公告)日:2012-05-09

    申请号:EP11186184.5

    申请日:2005-09-09

    摘要: The invention relates to the field of separation by distillation of 6-aminocapronitrile (ACN) and hexamethylenediamine (HMD) from a mixture comprising ACN, HMD, tetrahydrozaepine (THA), adiponitrile (ADN) and low boilers (LB). A method for producing a distillate stream comprising HMD is disclosed, which is suitable for the production of Nylon-6,6. The tails stream from the distillation of the mixture can be further distilled to produce a distillate comprising ACN and THA, which is particularly suitable for use in the production of caprolactam and Nylon-6 from the caprolactam. Process conditions of the method of the invention disfavor the production of 2-cyanocyclopentylideneimine (CPI).

    摘要翻译: 本发明涉及通过从包含ACN,HMD,四氢氮杂(THA),己二腈(ADN)和低沸点(LB))的混合物中蒸馏出6-氨基己腈(ACN)和六亚甲基二胺(HMD)的分离领域。 公开了一种生产包含HMD的馏出物流的方法,其适用于生产尼龙-6,6。 来自混合物蒸馏的尾巴料流可以进一步蒸馏,以产生包含ACN和THA的馏出物,其特别适用于从己内酰胺制备己内酰胺和尼龙-6。 本发明方法的工艺条件不利于2-氰基环戊烯亚胺(CPI)的生产。

    PREPARATION OF CYANO-ALIPHATIC ALDEHYDES
    77.
    发明公开
    PREPARATION OF CYANO-ALIPHATIC ALDEHYDES 审中-公开
    HERSTELLUNG VON CYANO-ALIPHATIS​​CHEN ALDEHYDEN

    公开(公告)号:EP2348015A2

    公开(公告)日:2011-07-27

    申请号:EP11003274.5

    申请日:2008-08-21

    摘要: A process for preparing one or more cyano-aliphatic aldehydes is described. The process comprises (a) preparing an olefinically-unsaturated cyano-aliphatic composition via a Diels Alder reaction of a diene and a dienophile composition; (b) contacting in a hydroformylation zone the olefinically-unsaturated cyano-aliphatic composition with carbon monoxide and hydrogen in the presence of a transition metal-organophosphorus ligand complex catalyst under hydroformylation conditions sufficient to prepare a hydroformylation product (c) mixing in an extraction zone the hydroformylation product composition with water under conditions sufficient to obtain by phase separation a nonpolar phase a polar phase comprising water and the one or more cyano-aliphatic aldehydes; (d) separating the one or more cyano-aliphatic aldehyde products from the hydroformylation product composition.

    摘要翻译: 描述了制备一种或多种氰基 - 脂族醛的方法。 该方法包括(a)通过二烯的Diels Alder反应和亲双烯体组合物制备烯属不饱和的氰基 - 脂族组合物; (b)在加氢甲酰化区中,在过渡金属 - 有机磷配位体配位体催化剂的存在下,在足以制备加氢甲酰化产物的加氢甲酰化条件下,在烯烃不饱和的氰基 - 脂族组合物中与一氧化碳和氢气接触,(c)在提取区 所述加氢甲酰化产物组合物在足以通过相分离获得非极性阶段的水的条件下,所述非极性相包含水和所述一种或多种氰基 - 脂族醛的极性相; (d)从加氢甲酰化产物组合物中分离出一种或多种氰基 - 脂族醛产物。